Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Vertex Pharmaceuticals Inc Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

$3.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$283.23 - $323.1 $1.19 Million - $1.36 Million	-4,202 Reduced 54.93%	3,448 $1.09 Million
Q4 2022 Jan 19, 2023	SELL	$285.76 - $321.48 $921,576 - $1.04 Million	-3,225 Reduced 29.66%	7,650 $2.21 Million
Q3 2022 Oct 18, 2022	BUY	$273.83 - $305.53 $2.4 Million - $2.68 Million	8,760 Added 414.18%	10,875 $3.15 Million
Q2 2022 Jul 19, 2022	BUY	$234.96 - $292.55 $106,906 - $133,110	455 Added 27.41%	2,115 $596,000
Q1 2022 Apr 13, 2022	BUY	$221.42 - $260.97 $367,557 - $433,210	1,660 New	1,660 $439,000
Q4 2021 Jan 25, 2022	SELL	$177.01 - $223.45 $1.27 Million - $1.6 Million	-7,177 Closed	0 $0
Q2 2021 Jul 16, 2021	SELL	$187.49 - $221.1 $55,497 - $65,445	-296 Reduced 3.96%	7,177 $1.45 Million
Q1 2021 Apr 20, 2021	BUY	$207.02 - $241.31 $550,259 - $641,401	2,658 Added 55.2%	7,473 $1.61 Million
Q4 2020 Jan 20, 2021	BUY	$207.01 - $276.09 $996,753 - $1.33 Million	4,815 New	4,815 $1.12 Million
Q3 2020 Oct 20, 2020	SELL	$255.65 - $303.1 $1.47 Million - $1.75 Million	-5,767 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$225.48 - $295.8 $1.3 Million - $1.71 Million	5,767 New	5,767 $1.67 Million
Q1 2020 Apr 23, 2020	SELL	$199.77 - $247.81 $791,089 - $981,327	-3,960 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$166.71 - $223.91 $2.15 Million - $2.89 Million	-12,895 Reduced 76.51%	3,960 $867,000
Q3 2019 Oct 29, 2019	BUY	$166.23 - $187.09 $897,974 - $1.01 Million	5,402 Added 47.17%	16,855 $2.8 Million
Q2 2019 Jul 17, 2019	SELL	$164.61 - $190.37 $167,572 - $193,796	-1,018 Reduced 8.16%	11,453 $2.05 Million
Q1 2019 Apr 29, 2019	BUY	$163.73 - $194.7 $1.57 Million - $1.86 Million	9,571 Added 330.03%	12,471 $2.27 Million
Q1 2018 May 02, 2018	SELL	$151.6 - $177.13 $3.89 Million - $4.54 Million	-25,647 Reduced 89.84%	2,900 $461,000
Q4 2017 Jan 26, 2018	BUY	$137.28 - $155.55 $3.92 Million - $4.44 Million	28,547	28,547 $4.34 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.1 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.61 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.33 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.06 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Account